These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
27. Tryptophan and hepatic coma. Ono J; Hutson DG; Dombro RS; Levi JU; Livingstone A; Zeppa R Gastroenterology; 1978 Feb; 74(2 Pt 1):196-200. PubMed ID: 620892 [TBL] [Abstract][Full Text] [Related]
28. Visual evoked potential: a diagnostic tool for the assessment of hepatic encephalopathy. Zeneroli ML; Pinelli G; Gollini G; Penne A; Messori E; Zani G; Ventura E Gut; 1984 Mar; 25(3):291-9. PubMed ID: 6421664 [TBL] [Abstract][Full Text] [Related]
29. [Therapy of hepatic encephalopathy. Changes in the cerebrospinal fluid concentration of catecholamine neurotransmitters, ammonia and amino acids in the course of an infusion treatment with branched-chain amino acids]. Rössle M; Herz R; Lehmann G; Luft M; Gerok W Infusionsther Klin Ernahr; 1982 Oct; 9(5):256-8. PubMed ID: 7141673 [TBL] [Abstract][Full Text] [Related]
30. Urinary and serum octopamine in patients with portal-systemic encephalopathy. Manghani KK; Lunzer MR; Billing BH; Sherlock S Lancet; 1975 Nov; 2(7942):943-6. PubMed ID: 53430 [TBL] [Abstract][Full Text] [Related]
32. Plasma amino acids imbalance in patients with liver disease. Cascino A; Cangiano C; Calcaterra V; Rossi-Fanelli F; Capocaccia L Am J Dig Dis; 1978 Jul; 23(7):591-8. PubMed ID: 685924 [TBL] [Abstract][Full Text] [Related]
33. An approach to nutritional therapy of hepatic encephalopathy by normalization of deranged amino acid patterns in serum. Watanabe A; Higashi T; Nagashima H Acta Med Okayama; 1978 Dec; 32(6):427-40. PubMed ID: 154828 [TBL] [Abstract][Full Text] [Related]
34. In vitro adsorption of possible aetiological factors of hepatic encephalopathy. Chamuleau RA; Schoemaker LP; Smit EM Int J Artif Organs; 1979 Nov; 2(6):284-8. PubMed ID: 389835 [TBL] [Abstract][Full Text] [Related]
35. Parenteral nutrition and coma therapy with amino acids in hepatic failure. Striebel JP; Holm E; Lutz H; Storz LW JPEN J Parenter Enteral Nutr; 1979; 3(4):240-6. PubMed ID: 113592 [No Abstract] [Full Text] [Related]
36. Biochemical monitoring of encephalopathy in liver failure. Lancet; 1980 Oct; 2(8198):783-4. PubMed ID: 6107458 [No Abstract] [Full Text] [Related]
37. Cerebral blood flow and plasma free tryptophan in cirrhotics with and without hepatic encephalopathy. Testa R; Rodriguez G; Arvigo F; Grasso A; Gris A; Nobili F; Marenco S; Rosadini G; Celle G Ital J Neurol Sci; 1989 Aug; 10(4):415-21. PubMed ID: 2793414 [TBL] [Abstract][Full Text] [Related]
38. The role of plasma amino acids in hepatic encephalopathy. Fischer JE; Funovics JM; Aguirre A; James JH; Keane JM; Wesdorp RI; Yoshimura N; Westman T Surgery; 1975 Sep; 78(3):276-90. PubMed ID: 807982 [TBL] [Abstract][Full Text] [Related]
39. Alteration in plasma amino acid concentrations following subtotal hepatectomy in dogs. Nagasue N; Kanashima R; Inokuchi K Ann Chir Gynaecol; 1981; 70(2):50-5. PubMed ID: 6797341 [TBL] [Abstract][Full Text] [Related]
40. The role of protein metabolism in 204 liver cirrhotics with and without hepatic encephalopathy. II. Amino acids, free phenols and indoles. Müting D; Perisoara A; Baum G; Flasshoff HJ; Bucsis L Hepatogastroenterology; 1986 Apr; 33(2):66-70. PubMed ID: 3721389 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]